Plasma HIV-1 RNA levels during antiretroviral therapy: how low is low enough?
about
HIV drug resistance detected during low-level viraemia is associated with subsequent virologic failureClinical evaluation of a low cost, in-house developed real-time RT-PCR human immunodeficiency virus type 1 (HIV-1) quantitation assay for HIV-1 infected patients.Lack of correlation between reaction speed and analytical sensitivity in isothermal amplification reveals the value of digital methods for optimization: validation using digital real-time RT-LAMPConsolidation of molecular testing in clinical virology.Cannabis use and HIV antiretroviral therapy adherence and HIV-related symptoms.Low-level viraemia, measured as viraemia copy-years, as a prognostic factor for medium-long-term all-cause mortality: a MASTER cohort study.Reduced adherence to antiretroviral therapy is associated with residual low-level viremia.A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replication.Very low level viraemia and risk of virological failure in treated HIV-1-infected patients.Low-level HIV-1 viraemia in patients on HAART: risk factors and management in clinical practice.Comparing HIV viral load assays and frequency of low level virological rebound in clinical practice.An undetectable polymerase chain reaction signal in routine HIV plasma viral load monitoring is associated with better virological outcomes in patients receiving highly active antiretroviral therapy.Avoidable workload of care for patients living with HIV infection in Abidjan, Côte d'Ivoire: A cross-sectional study
P2860
Q34781706-815C5F97-C1FC-4E81-BB2F-23C523B1CEF8Q35112701-14381168-50D2-4DDD-88C3-0C7688ABA81BQ36532714-DA7347E9-AD16-4700-A9E1-9E20BCB78062Q38779627-D6101119-7DF1-470F-B372-7489642FAD1AQ39240394-A766A317-38E4-443D-9C11-25544260B675Q39375437-96479E44-E099-4D25-B198-D8F37AD9771BQ40164081-60A3EBED-41CA-4543-94FD-54833007E5BDQ40463006-141E83A1-7FE6-411B-BDA4-5E21F998080AQ40593936-BCC8321E-309A-40B6-993D-39A009C989C7Q41276669-384A901D-9EBB-4256-8D69-2E768DCF9DAFQ42230298-CFFDC750-8F51-46C8-B804-38FC145B5CB8Q42263784-3CFFC6AF-6679-4083-B414-76810EDFDFAAQ58708707-50D1A1BA-C9E6-4D97-90A9-2DD6D0E86FFA
P2860
Plasma HIV-1 RNA levels during antiretroviral therapy: how low is low enough?
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Plasma HIV-1 RNA levels during antiretroviral therapy: how low is low enough?
@en
Plasma HIV-1 RNA levels during antiretroviral therapy: how low is low enough?
@nl
type
label
Plasma HIV-1 RNA levels during antiretroviral therapy: how low is low enough?
@en
Plasma HIV-1 RNA levels during antiretroviral therapy: how low is low enough?
@nl
prefLabel
Plasma HIV-1 RNA levels during antiretroviral therapy: how low is low enough?
@en
Plasma HIV-1 RNA levels during antiretroviral therapy: how low is low enough?
@nl
P2860
P356
P1476
Plasma HIV-1 RNA levels during antiretroviral therapy: how low is low enough?
@en
P2093
Rajesh T Gandhi
P2860
P304
P356
10.1093/CID/CIR933
P407
P577
2012-01-11T00:00:00Z